News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
DENKHAUS DONALD A
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/04/2023 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 60,000 options to buy
@ $1.13, valued at
$67.8k
|
|
01/27/2023 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 50,000 options to buy
@ $0.79, valued at
$39.5k
|
|
12/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/15/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Sold 20,000 shares
@ $15.34, valued at
$306.8k
|
|
02/16/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 12,000 restricted stock units
@ $0 |
|
01/11/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 40,000 options to buy
@ $2.53, valued at
$101.2k
|
|
01/06/2022 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 50,000 options to buy
@ $3.35, valued at
$167.5k
|
|
12/30/2021 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 20,000 options to buy
@ $7.07, valued at
$141.4k
|
|
12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/23/2020 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Exercised 1,333 restricted stock units
@ $0 |
|
12/04/2019 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 33,500 options to buy
@ $4.64, valued at
$155.4k
Granted 4,000 restricted stock units
@ $0 |
|
12/28/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Bought 25,000 shares
@ $1.91, valued at
$47.8k
|
|
12/21/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 25,000 options to buy
@ $2.24, valued at
$56k
|
|
12/17/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Bought 60,000 shares
@ $2.48, valued at
$148.8k
|
|
06/11/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Bought 20,000 shares
@ $3.41, valued at
$68.2k
|
|
05/31/2018 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Bought 20,000 shares
@ $3.75, valued at
$75k
|
|
01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2017 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 30,000 options to buy
@ $1.13, valued at
$33.9k
|
|
06/17/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
01/07/2016 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Bought 25,000 shares
@ $2.03, valued at
$50.8k
|
|
01/04/2016 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICALS, INC.
Txns:
| Granted 20,000 options to buy
@ $2.53, valued at
$50.6k
|
|
04/30/2015 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Bought 5,000 shares
@ $3.25, valued at
$16.3k
|
|
04/28/2015 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Bought 15,000 shares
@ $3.71, valued at
$55.7k
|
|
03/30/2015 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on CATALYST PHARMACEUTICAL PARTNERS, INC.
Txns:
| Bought 5,000 shares
@ $4.17, valued at
$20.9k
|
|
08/27/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/21/2009 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on NOVEN PHARMACEUTICALS INC |
05/27/2009 |
4
| DENKHAUS DONALD A (Director) has filed a Form 4 on NOVEN PHARMACEUTICALS INC |
|
|